Marathon Asset Management (UK)’s Organon & Co OGN Stock Holding History

Marathon Asset Management (UK)’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,008,331	Closed	-$17.5M	–	89
2023 Q3	$17.5M	Sell	1,008,331 -48,744	-5%	-$1.02M	0.54%	70
2023 Q2	$22M	Sell	1,057,075 -118,508	-10%	-$2.58M	0.62%	65
2023 Q1	$27.6M	Sell	1,175,583 -184,738	-14%	-$4.96M	0.77%	52
2022 Q4	$38M	Buy	1,360,321 +115,048	+9%	+$2.94M	1.02%	37
2022 Q3	$29.1M	Sell	1,245,273 -1,036,899	-45%	-$31.3M	0.87%	53
2022 Q2	$77M	Sell	2,282,172 -129,410	-5%	-$4.53M	1.29%	31
2022 Q1	$84.2M	Sell	2,411,582 -192,709	-7%	-$6.59M	1.14%	38
2021 Q4	$79.3M	Buy	2,604,291 +2,468,966	+1,824%	+$80.4M	0.98%	45
2021 Q3	$4.44M	Sell	135,325 -3,990	-3%	-$128K	0.05%	79
2021 Q2	$4.22M	Buy	+139,315	New	+$4.59M	0.05%	92

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SSM

Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SPC

Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

Marathon Asset Management (UK)'s OGN Position: Q4 2023 in Review

Marathon Asset Management (UK) sold out of Organon & Co (OGN) in Q4 2023, closing a stake of 1,008,331 shares — an estimated $17.5M sold.

Marathon Asset Management (UK) first reported a position in OGN in Q2 2021 and held it in 10 quarters. The position peaked at $84.2M in Q1 2022. 719 funds tracked by Wall St. Rank hold OGN as of Q4 2023.

Marathon Asset Management (UK) reported no remaining Organon & Co position as of Q4 2023 after selling out during the quarter.
Marathon Asset Management (UK) sold 1,008,331 Organon & Co shares in Q4 2023, an estimated $17.5M.
Marathon Asset Management (UK) first reported a position in Organon & Co in Q2 2021 and held it in 10 quarters.
Marathon Asset Management (UK)'s Organon & Co position peaked at $84.2M in Q1 2022.
719 funds tracked by Wall St. Rank held Organon & Co as of Q4 2023.

Based on Marathon Asset Management (UK)'s 13F filing for Q4 2023, filed 12 Feb 2024.